Peer-reviewedCC BYBiomedicines
Assessment of the Safety of a Combined Medicinal Agent Based on Probiotic Lactic Acid Bacteria and the Natural Component Glycyrrhiza glabra
- 1LLP «Industrial Microbiology», Al-Farabi Ave 89/44, Almaty 050040, Kazakhstan; (I.R.);
- 2, Bogenbay Batyr St., 105, Almaty 050010, Kazakhstan
- 3Department of Botany and Agroecology, , Al-Farabi Ave 71, Almaty 050040, Kazakhstan
Related
- Combined statin probiotic treatment mitigates atherogenic dyslipidemia fueling NAFLD in high-cholesterol-diet fed rats
- In Vitro Assessment of Chemically Modified Probiotic Bacteria as Receptor-Mimic Decoys for Cholera Toxin B Subunit
- Recognizing Nocturnal Respiratory Instability as a Key Component of Heart Failure Assessment
- Quantitative Glandular Tissue Component Assessment on Breast Ultrasound Using an Anatomically Constrained Deep Learning Framework
- Probiotic-Enriched Yogurt with Encapsulated Lacticaseibacillus rhamnosus and Bacillus clausii: Product Characterization and Quality of Life Assessment in Type 2 Diabetes
BibTeX
@article{ratnikova2026assessment,
title = {{Assessment of the Safety of a Combined Medicinal Agent Based on Probiotic Lactic Acid Bacteria and the Natural Component Glycyrrhiza glabra}},
author = {Irina Ratnikova and Amankeldi Sadanov and Baiken Baimakhanova and Erik Shorabaev and Saltanat Orazymbet and Elmira Namaz and Nurshad Utegenova},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701990},
note = {CC BY},
}
RIS
TY - JOUR
TI - Assessment of the Safety of a Combined Medicinal Agent Based on Probiotic Lactic Acid Bacteria and the Natural Component Glycyrrhiza glabra
AU - Irina Ratnikova
AU - Amankeldi Sadanov
AU - Baiken Baimakhanova
AU - Erik Shorabaev
AU - Saltanat Orazymbet
AU - Elmira Namaz
AU - Nurshad Utegenova
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701990
SN - 2227-9059
ER -